Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

With the Federal Reserve previously engaged in a bitter – and seemingly, at times desperate – struggle against blisteringly hot inflation, the narrative for growth…

Dear SIDU Stock Fans, Mark Your Calendars for a Q1 2024 Launch

Although Sidus Space garnered intense interest for announcing an upcoming satellite launch, SIDU stock remains highly speculative.

Why Is Mullen Automotive (MULN) Stock Up 25% Today?

With Mullen Automotive delivering another set of vehicles, MULN stock enjoyed a credibility lift. Still, concerns loom large.

Green Energy Goliaths: 3 Renewable Energy Stocks With Robust Growth Projections

No matter what the circumstances, renewable energy stocks offer tremendous relevance. Basically, that’s where the political and ideological winds are directing the money toward. Even…

7 Stocks to Buy if the Fed Goes Through With Interest Rate Cuts

While inflation may have been the theme of 2022, disinflation could be the defining label for the outgoing year, thus warranting a closer examination of…

Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee Ratios

Inundated with myriad ways of assessing publicly traded companies, one unique metric could intrigue investors seeking opportunities in 2024 and that would be high-efficiency stocks.…

Why Is Cytokinetics (CYTK) Stock Up 70% Today?

With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest.

MULN Stock Alert: Mullen Enters New Phase of Battery Pack Testing

Although Mullen Automotive delivered seemingly exciting technology and delivery news, skepticism still clouds MULN stock.

Gen Z Growth Picks: 3 Stocks Capturing the Next Generation’s Attention

While the past several years have focused on the whims and desires of millennials, it’s time to shift this paradigm by focusing largely on Gen…

2023 Stock Market Rollercoaster: Hits, Misses, and Lessons Learned

With another year about to enter the books, it’s time to consider a broad stock market review. Sure, as various positive-thinking gurus may assert, you’ve…